Registry of Very Early Estrogen and Anovulation due to Functional Hypothalamic Amenorrhea.

Overview

About this study

The purpose of this study is to to build a registry of women with early estrogen loss due to FHA to understand the prevalence, racial and ethnic diversity of this condition.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 years to 40 years.
  • 3 or more months of consecutive amenorrhea with a diagnosis of functional hypothalamic amenorrhea or screening hormones.
  • LH to FSH ratio < 1.
  • Premenopausal status determined by the WISE criteria.
  • Able to give informed consent.
  • Able to read English.

Exclusion Criteria:

  • Parturition/lactating in the last 6-12 months.
  • Lack of consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/19/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Chrisandra Shufelt, M.D.

Open for enrollment

Contact information:

Katie Cruz

(507) 284-7866

Cruz.Katie@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Chrisandra Shufelt, M.D.

Open for enrollment

Contact information:

Chrisandra Shufelt M.D.

(904) 953-7224

Shufelt.Chrisandra@mayo.edu

More information

Publications

Publications are currently not available